IIM
INMB icon

INTECH Investment Management’s INmune Bio INMB Stock Holding History

INTECH Investment Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,327
Closed -$26.2K – 2452
2025
Q2 		$26.2K Buy
+11,327
New +$83.1K ﹤0.01% 2446

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

INTECH Investment Management's INMB Position: Q3 2025 in Review

INTECH Investment Management sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 11,327 shares — an estimated $26.2K sold.

INTECH Investment Management first reported a position in INMB in Q2 2025 and held it in 1 quarter. The position peaked at $26.2K in Q2 2025. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • INTECH Investment Management reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • INTECH Investment Management sold 11,327 INmune Bio shares in Q3 2025, an estimated $26.2K.
  • INTECH Investment Management first reported a position in INmune Bio in Q2 2025 and held it in 1 quarter.
  • INTECH Investment Management's INmune Bio position peaked at $26.2K in Q2 2025.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.